SUPRIYA LIFESCIENCE
|
The Current P/E Ratio of SUPRIYA LIFESCIENCE is 33.51.
| Share Price | ₹870.4 | Jul 14,2026 |
| Market Cap | ₹7,006.7 Cr | |
| Earnings-TTM | ₹209.1 Cr | TTM-Standalone Results |
| Price/Earnings | 33.51x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SUPRIYA LIFESCIENCE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹7,006.7 Cr] as on Jul 14,2026
(/) Earnings [ ₹209.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 33.51x ]
Thus, for SUPRIYA LIFESCIENCE , the investors are currently willing to pay 33.51 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUPRIYA LIFESCIENCE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUPRIYA LIFESCIENCE over the last five years.
Historical PE (Price/Earnings) ratio chart of SUPRIYA LIFESCIENCE
PE Ratio Performance Analysis for SUPRIYA LIFESCIENCE
- SUPRIYA LIFESCIENCE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.41x.
- SUPRIYA LIFESCIENCE 's operated at median p/e ratio of 22.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUPRIYA LIFESCIENCE 's p/e ratio peaked in Mar2025 at 31.41x.
- SUPRIYA LIFESCIENCE 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does SUPRIYA LIFESCIENCE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SUPRIYA LIFESCIENCE | 209.12 | 33.51 | 7,006.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 40.25 | 465,507.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 74.28 | 190,744.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 78.70 | 168,250.0 |
| CIPLA LTD | 3,869.79 | 30.03 | 116,213.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.09 | 103,980.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.25 | 104,509.0 |
| LUPIN LTD | 5,355.47 | 21.08 | 112,912.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.50 | 113,102.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.52 | 89,344.7 |
| LAURUS LABS LTD | 889.85 | 94.70 | 84,270.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUPRIYA LIFESCIENCE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 21.08x |
| Max industry PE | 94.70x |
| Median industry PE | 33.51x |
| Average industry PE | 45.45x |
You may also like the below Video Courses